๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Genetic mode of action of cocarcinogens and tumor promoters in yeast and mice

โœ Scribed by Fahrig, Rudolf


Publisher
Springer
Year
1984
Tongue
English
Weight
824 KB
Volume
194
Category
Article
ISSN
0026-8925

No coin nor oath required. For personal study only.

โœฆ Synopsis


In experiments with yeast, cocarcinogens were found to be comutagenic and antirecombinogenic, tumor promoters to be corecombinogenic and antimutagenic. Substances that were cocarcinogens as well as tumor promoters had an intermediary effect. These results were confirmed in the mammalian spot test: By in vivo treatment of mice with the cocarcinogen catechol and the tumor promoter limonene carcinogen-induced recombination due to mitotic crossing over and gene mutations was reduced and enhanced, respectively.

Our results support the hypothesis that mutagenesis is the mechanism by which chemicals induce malignancy, and that cocarcinogens modify the process by enhancement of mutagenicity whereas tumor promoters effect carcinogenesis by increase of the spontaneous frequency of recombination. In addition, induced mitotic recombination in mammals in vivo has been demonstrated for the first time.


๐Ÿ“œ SIMILAR VOLUMES


Cocarcinogenic and tumor-promoting capab
โœ N. Z. Baturay; L. D. Trombetta ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 662 KB

Numerous chemicals to which humans are exposed either therapeutically or as a result of living in an industrial environment constitute a potential threat as carcinogens, mutagens, and/or tumor promoters and cocarcinogens. Anthralin, and antipsoriatic agent, acts as a tumor promoter for Balb/c-3T3 mo

Comparison of chemical carcinogen skin t
โœ John P. Sundberg; Beth A. Sundberg; Wesley G. Beamer ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 611 KB

Chemical carcinogen induction of skin tumors in mice was investigated to determine (i) if tumor induction efficacy was modified by single gene mutations, (ii) if the histologic types of the tumors varied with these mutations, and (iii) if a novel papillomavirus was involved as a cocarcinogen. A two-